This new pilot program is designed to accelerate the development and review of certain drugs and biological products that are aligned with U.S. national health priorities and to enhance the health interests of Americans.
Recommend0 recommendationsPublished in US National Health Agency Sources
“Ever wondered why your neighborhood looks how it does?” Jennifer Rangel once asked herself this question. To find an answer, Rangel, got a master’s degree in urban planning. Along the way, this Latina planner learned that discriminatory urban planning practices, like the zoning of land, had been used for white advantage for over a century, …
The post Jennifer Rangel: Creating Bilingual Cartoons to Teach Zoning 101 appeared first on Salud America.
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health…
Sodas, juices, and other sugary drinks contribute to obesity and other health issues. This is why many communities are passing sugary drink taxes. This kind…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
FDA Commissioner’s National Priority Voucher Program. The Commissioner’s National Priority Voucher Program offers an unprecedented opportunity to reduce drug and biologic review times from 10-12 months to just 1-2 months.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
